Prot# 20050184: A Phase 2, Open-label, Randomized Clinical Trial of Skin Toxicity Treatment in Subjects Receiving Second-line FOLFIRI or Irinotecan Only Chemotherapy Concomitantly with Panitumumab

Project: Research project

Project Details

StatusFinished
Effective start/end date3/7/0711/4/08

Funding

  • Immunex Corporation (20050184)